Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Volpe

Showing results (221-230 of 820) with videos related to

Pageof 82
Sort By:
Journal of Clinical Hypertension (Greenwich, Conn.)|May 4, 2010
Hypertension as an underlying factor in heart failure with preserved ejection fractionMassimo Volpe, Robert McKelvie, Helmut Drexler
Circulation Research|April 1, 2021
Hypertension, a Moving Target in COVID-19: Current Views and PerspectivesCarmine Savoia, Massimo Volpe, Reinhold Kreutz
American Journal of Hypertension|December 1, 2018
How to Improve Patients' Adherence to Antihypertensive Therapy: A Simple Solution for a Big TroubleGiuliano Tocci, Vivianne Presta, Massimo Volpe
Current Hypertension Reports|August 3, 2005
Angiotensin II-receptor antagonist in the treatment of hypertensionMassimo Volpe, Giuliano Tocci, Erika Pagannone
Journal of Hypertension|February 8, 2013
Olmesartan-based therapies: an effective way to improve blood pressure control and cardiovascular protectionAlejandro de la Sierra, Massimo Volpe
High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension|January 25, 2023
Single-Pill Combination with Three Antihypertensive Agents to Improve Blood Pressure Control in Hypertension: Focus on Olmesartan-Based CombinationsMichel Burnier, Josep Redon, Massimo Volpe
Frontiers in Cardiovascular Medicine|December 17, 2020
Sacubitril/Valsartan: Potential Impact of ARNi "Beyond the Wall" of ACE2 on Treatment and Prognosis of Heart Failure Patients With Coronavirus Disease-19Speranza Rubattu, Giovanna Gallo, Massimo Volpe
High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension|June 9, 2025
"Add Life to Years Besides Years to Life" the Key Role of Prevention to Achieve a Valuable Health ObjectiveGiovanna Gallo, Massimo Fini, Massimo Volpe
Current Cardiology Reports|November 1, 2016
Hypertension in Patients with Heart Failure with Reduced Ejection FractionMassimo Volpe, Caterina Santolamazza, Giuliano Tocci
Clinical Science (London, England : 1979)|March 12, 2014
Atrial natriuretic peptide gene variants and circulating levels: implications in cardiovascular diseasesSperanza Rubattu, Sebastiano Sciarretta, Massimo Volpe
Pageof 82

Showing results (221-230 of 820) with videos related to

Sort By:
Pageof 82
Journal of Clinical Hypertension (Greenwich, Conn.)|May 4, 2010
Hypertension as an underlying factor in heart failure with preserved ejection fractionMassimo Volpe, Robert McKelvie, Helmut Drexler
Circulation Research|April 1, 2021
Hypertension, a Moving Target in COVID-19: Current Views and PerspectivesCarmine Savoia, Massimo Volpe, Reinhold Kreutz
American Journal of Hypertension|December 1, 2018
How to Improve Patients' Adherence to Antihypertensive Therapy: A Simple Solution for a Big TroubleGiuliano Tocci, Vivianne Presta, Massimo Volpe
Current Hypertension Reports|August 3, 2005
Angiotensin II-receptor antagonist in the treatment of hypertensionMassimo Volpe, Giuliano Tocci, Erika Pagannone
Journal of Hypertension|February 8, 2013
Olmesartan-based therapies: an effective way to improve blood pressure control and cardiovascular protectionAlejandro de la Sierra, Massimo Volpe
High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension|January 25, 2023
Single-Pill Combination with Three Antihypertensive Agents to Improve Blood Pressure Control in Hypertension: Focus on Olmesartan-Based CombinationsMichel Burnier, Josep Redon, Massimo Volpe
Frontiers in Cardiovascular Medicine|December 17, 2020
Sacubitril/Valsartan: Potential Impact of ARNi "Beyond the Wall" of ACE2 on Treatment and Prognosis of Heart Failure Patients With Coronavirus Disease-19Speranza Rubattu, Giovanna Gallo, Massimo Volpe
High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension|June 9, 2025
"Add Life to Years Besides Years to Life" the Key Role of Prevention to Achieve a Valuable Health ObjectiveGiovanna Gallo, Massimo Fini, Massimo Volpe
Current Cardiology Reports|November 1, 2016
Hypertension in Patients with Heart Failure with Reduced Ejection FractionMassimo Volpe, Caterina Santolamazza, Giuliano Tocci
Clinical Science (London, England : 1979)|March 12, 2014
Atrial natriuretic peptide gene variants and circulating levels: implications in cardiovascular diseasesSperanza Rubattu, Sebastiano Sciarretta, Massimo Volpe
Pageof 82